Start Date
September 30, 2007
Primary Completion Date
April 5, 2010
Study Completion Date
April 5, 2010
CT-2103/carboplatin
CT-2103 (175 mg/m2 10 min IV infusion) and carboplatin (AUC 6, 30 min IV infusion) on day 1 of each 21-day cycle for up to 6 cycles.
paclitaxel/carboplatin
Paclitaxel (175 mg/m2, 3 hr IV infusion) and carboplatin (AUC 6) (30 minute IV infusion) on day 1 of each 21-day cycle for up to 6 cycles.
Richmond University Medical Center, Staten Island
Lincoln Medical and Mental Health Center, New York
New York Medical College, Valhalla
Arena Oncology Associates, New York
Vita Hematology Oncology, P.C., Fountain Hill
Cancer Outreach Associates, LLC, Arlington
Horizon Institute for Clinical Research, Hollywood
Memorial Cancer Institute, Hollywood
Broward Oncology Associates, Fort Lauderdale
Pasco Pinellas Cancer Center, Tarpon Springs
The Family Cancer Center, Collierville
Mid-South Cancer Center, Germantown
Hattiesburg Clinic, Hattiesburg
Blood and Cancer Center, Canfield
Aultman Hospital Clinical Trials, Canton
UIMA, Inc / University of Cincinnati-Barrett Cancer Center, Cincinnati
Cancer Care Center, New Albany
Family Medicine of Vincennes Clinical Trials Center, Vincennes
Providence Medical Group, Terre Haute
Henry Ford Health System, Josephine Ford Cancer Center, Detroit
W. Michigan Regional Cancer & Blood Center, Free Soil
St Alexius Medical Center, Bismarck
Loyola University, Maywood
Joliet Oncology Hematology Associates, Ltd, Joliet
Hematology Oncology Consultants, Naperville
St. Louis University, St Louis
Columbia Comprehensive Cancer Care Clinics, Jefferson City
Kansas City Cancer Center, Overland Park
Hembree Regional Cancer Center, Fort Smith
University of Oklahoma Health Science Center, Oklahoma City
Mary Crowley Medical Research Center, Dallas
Southwest Regional Cancer Center, Austin
Lone Star Oncology Consultants, Austin
Northern Utah Associates, Ogden
Scottsdale Medical Specialists, Scottsdale
Mayo Clinic, Scottsdale
Las Vegas Cancer Center, Henderson
VA Sierra Nevada Health Care System, Reno
Clinical Trials & Research Institute, Montebello
Providence St. Joseph Medical Center, Burbank
Southwest Cancer Care, Escondido
Stanford Cancer Center, Stanford
Virginia Mason Medical Center, Seattle
Hartford Hospital, Hartford
Lead Sponsor
CTI BioPharma
INDUSTRY